Quantcast
Last updated on April 17, 2014 at 10:33 EDT

Latest The Scripps Research Institute Stories

2012-06-27 06:25:42

SAN DIEGO, June 27, 2012 /PRNewswire/ -- The Supreme Court is expected to issue its ruling on the health care reform bill later this week - but San Diego-based Scripps Health asserts the legislation will have far less impact on improving the nation's care delivery system than the steps already under way by private-sector health care providers. "Regardless of what the court decides, health care in this country is already changing and must keep evolving, because it's broken," said Chris Van...

2012-06-15 02:25:22

For Scripps Research, the Focused Deal Provides a Model for Future LA JOLLA, Calif., June 15, 2012 /PRNewswire-USNewswire/ -- The Scripps Research Institute today announced it has entered into a five-year collaboration with Bristol-Myers Squibb Company (NYSE:BMY) focused on applying novel chemistry to drug discovery and synthesis. The collaboration will revolve around support for projects of mutual interest to Bristol-Myers Squibb and a number of Scripps Research chemistry laboratories....

2012-06-14 02:25:38

SAN FRANCISCO, June 14, 2012 /PRNewswire/ -- Sutro Biopharma today announced that it has signed a licensing agreement with The Scripps Research Institute and will have access to "click chemistry," a modular synthetic approach that allows the assembly of new molecular entities by efficiently and reliably joining two molecular units together stably and irreversibly. The agreement with Scripps Research provides Sutro with a worldwide license to apply click chemistry for the synthesis of novel...

2012-06-07 14:23:28

SAN DIEGO, June 7, 2012 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTCBB: SRNE) today announced that it has received an Advanced Technology Small Business Technology Transfer Research (STTR) Fast Track grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health, or NIH. The peer-reviewed grant was awarded to support the Company's program to generate and develop novel human antibody therapeutics to combat Staphylococcus aureus...

2012-05-31 14:23:24

LA JOLLA, Calif., May 31, 2012 /PRNewswire/ -- Scripps Research Institute Professor Richard A. Lerner, MD, has won a prestigious international honor, the Prince of Asturias Award for Scientific and Technical Research, according to an announcement made today by the Prince of Asturias Foundation. Lerner shares the award with British biochemist Sir Gregory Winter, PhD. Sometimes called the "Spanish Nobel Prize," the Prince of Asturias Award for Scientific and Technical Research is bestowed for...

2012-03-29 06:26:27

The New Molecules Could Lead to Unique Treatments for Obesity, Diabetes, High Cholesterol, and Sleep Disorders JUPITER, Fla., March 29, 2012 /PRNewswire-USNewswire/ -- Scientists from the Florida campus of The Scripps Research Institute have synthesized a pair of small molecules that dramatically alter the core biological clock in animal models, highlighting the compounds' potential effectiveness in treating a remarkable range of disorders--including obesity, diabetes, high cholesterol,...

Blood Test May Predict Heart Attack
2012-03-22 08:30:51

A new blood test developed to predict heart attacks as much as two weeks in advance could be a savior to more than 2.5 million Americans at risk, medical news site MyHealthNewsDaily reports. The test, which measures circulating endothelial cells (CECs) in the blood, was used in a study of 50 patients led by Scripps Translational Science Institute (STSI) — a collaborative program between Scripps Health and the Scripps Research Institute (SRI). CECs in heart attack patients are...

2012-03-22 02:24:56

LA JOLLA, Calif., March 22, 2012 /PRNewswire/ -- Anaphore Inc. today announced that it has acquired Shanghai-based RuiYi Inc., bringing the company a powerful biologics drug discovery platform focused on the discovery and development of biologic therapies targeting G protein coupled receptors (GPCRs). RuiYi was founded by Raymond Stevens, PhD., of The Scripps Research Institute (TSRI) and TSRI alumni Fei Xu, Ph.D. of Shanghai, China. "The acquisition of RuiYi in China allows Anaphore to...

2012-03-21 10:24:59

SAN DIEGO, March 21, 2012 /PRNewswire/ -- New findings from a landmark research study led by Scripps Translational Science Institute (STSI) - a collaborative program between Scripps Health and The Scripps Research Institute (TSRI) - shows a promising new blood test may be useful in helping doctors predict who is at risk for an imminent heart attack. (Photo: http://photos.prnewswire.com/prnh/20120321/LA74303) Results of the study titled, "Characterization of Circulating Endothelial...

2012-03-06 18:01:00

New Drug Helps Pre-Term Infants Breathe LA JOLLA, Calif., March 6, 2012 /PRNewswire-USNewswire/ -- Scientific advances at The Scripps Research Institute have led to a new drug Surfaxin® (lucinactant), approved today by the U.S. Food and Drug Administration (FDA) to treat infant respiratory distress syndrome. "I am excited that our scientific findings will help save lives," said Charles Cochrane, M.D., professor emeritus at Scripps Research. "Many years of work in our basic...